Skip to main content

Table 1 Characteristics of the subjects in the study

From: Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves’ disease

Group

n

Gender

M/F

Age

TRAb

(IU/L)

TPOAb

(IU/L)

TSH

(mIU/L)

FT3

(pg/ml)

FT4

(ng/dl)

Methimazole

(mg)

GD

52

18/34

36.46 ± 11.53

11.98 ± 20.53

179.18 ± 253.26

0.16 ± 0.41

6.17 ± 4.97

1.88 ± 1.35

14.71 ± 8.37

HT

39

12/27

37.89 ± 15.59

 N.A.

221.62 ± 317.05

5.55 ± 9.80

3.2 0 ± 0.67

0.86 ± 0.17

 N.A.

HC

23

12/11

39.96 ± 12.14

< 1.75

< 3.5

 N.A.

N.A.

N.A.

N.A.

  1. TRAb thyrotropin receptor autoantibody; TPOAb thyroid peroxidase autoantibody; TSH thyroid stimulating hormone; FT3 free triiodothyronine; FT4 free thyroxine; GD Graves’ disease; HT Hashimoto’s thyroiditis; FT4 free thyroxine